Skip to main content
. 2022 Apr 30;162(4):804–814. doi: 10.1016/j.chest.2022.04.145

Figure 2.

Figure 2

A, B, Histograms showing (A) oxygen-free days and (B) ventilator-free days among the first 698 participants in the Passive Immunity Trial for Our Nation trial, a randomized trial of COVID-19 convalescent plasma vs placebo among adults hospitalized with COVID-19 and hypoxemia in the United States.